Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Peripheral Nervous System Diseases 5Lymphoma 5Head and Neck Neoplasms 4Breast Neoplasms 4Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Colorectal Neoplasms 3Stomatitis 2Stomach Neoplasms 2Sarcoma 2Pain 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasm Metastasis 2Multiple Myeloma 2Mucositis 2Malnutrition 2Wilms Tumor 1Vaso-Occlusive Crises 1Squamous Cell Carcinoma of Head and Neck 1Sarcopenia 1Recurrence 1Radiation Injuries 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Oral Complications 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Multiple Endocrine Neoplasia Type 1 1Malignant mesenchymal tumor 1

Interventions

Ifosfamide 30Methotrexate 29Doxorubicin 26Cyclophosphamide 24Cisplatin 22Filgrastim 18Etoposide 17Gemcitabine 16Leucovorin 14Magnetic Resonance Spectroscopy 11Temozolomide 10Specimen Handling 10cabozantinib 9apatinib 9X-Rays 9Carboplatin 9fludarabine 8Radiotherapy 8Nivolumab 8Neoadjuvant Therapy 8Irinotecan 8Granulocyte Colony-Stimulating Factor 8Drug Therapy 8Docetaxel 8Zoledronic Acid 7Vincristine 7Sirolimus 7Phantoms, Imaging 7Biopsy 7mifamurtide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Glutamine × Clear all
NCT00334984 2013-07-11

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Children's Oncology Group

Phase NA Withdrawn
Sarcoma

Malignant mesenchymal tumor, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Osteosarcoma, Dermatofibrosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡